Abstract:The Cancer Proteome Atlas (TCPA) project collects reverse-phase protein arrays (RPPA)-based proteome datasets from nearly 8000 samples across 32 cancer types. This study aims to investigate the pan-cancer proteome signature and identify cancer subtypes of glioma, kidney cancer, and lung cancer based on TCPA data. We first visualized the tumor clustering models using t-distributed stochastic neighbour embedding (t-SNE) and biclustering heatmap. Then, three feature selection methods (pyHSICLasso, XGBoost, and Random Forest) were performed to select protein features for classifying cancer subtypes in training dataset, and the LibSVM algorithm was empolyed to test classification accuracy in the validation dataset. Clustering analysis revealed that different kinds of tumors have relatively distinct proteomic profiling based on tissue or origin. We identified 20, 10, and 20 protein features with the highest accuracies in classifying subtypes of glioma, kidney cancer, and lung cancer, respectively. The predictive abilities of the selected proteins were confirmed by receiving operating characteristic (ROC) analysis. Finally, the Bayesian network was utilized to explore the protein biomarkers that have direct causal relationships with cancer subtypes. Overall, we highlight the theoretical and technical applications of machine learning based feature selection approaches in the analysis of high-throughput biological data, particularly for cancer biomarker research. Significance: Functional proteomics is a powerful approach for characterizing cell signaling pathways and understanding their phenotypic effects on cancer development. The TCPA database provides a platform to explore and analyze TCGA pan-cancer RPPA-based protein expression. With the advent of the RPPA technology, the availability of high-throughput data in TCPA platform has made it possible to use machine learning methods to identify protein biomarkers and further differentiate subtypes of cancer based on proteomic data. In this study, we highlight the role of feature selection and Bayesian network in discovery protein biomarker for classifying cancer subtypes based on functional proteomic data. The application of machine learning methods in the analysis of high-throughput biological data, particularly for cancer biomarker researches, which have potential clinical values in developing individualized treatment strategies.

PCA-constrained multi-core matrix fusion network: A novel approach for cancer subtype identification

Multi-Omics Data Fusion for Cancer Molecular Subtyping Using Sparse Canonical Correlation Analysis

Multi-Omics Data Fusion via a Joint Kernel Learning Model for Cancer Subtype Discovery and Essential Gene Identification

Multi-layer matrix factorization for cancer subtyping using full and partial multi-omics dataset

Discovering Cancer Subtypes Via an Accurate Fusion Strategy on Multiple Profile Data

MMKNF: Integrating multi-omics data to identify cancer subtypes based on multi-kernel network fusion

MDICC: novel method for multi-omics data integration and cancer subtype identification

MoGCN: A Multi-Omics Integration Method Based on Graph Convolutional Network for Cancer Subtype Analysis

Using feature selection and Bayesian network identify cancer subtypes based on proteomic data

Cancer Subtype Recognition Based on Laplacian Rank Constrained Multiview Clustering.

IPFMC: an iterative pathway fusion approach for enhanced multi-omics clustering in cancer research

A Multimodal Graph Neural Network Framework of Cancer Molecular Subtype Classification

MRGCN: cancer subtyping with multi-reconstruction graph convolutional network using full and partial multi-omics dataset

Breast Cancer Subtype by Imbalanced Omics Data Through A Deep Learning Fusion Model

Molecular Subtyping of Cancer Based on Robust Graph Neural Network and Multi-Omics Data Integration

DeepTpNet: A Deep Learning Approach to Identify Cancer Subtypes Based on Multi-omics Data.

Molecular Subtyping of Cancer Based on Distinguishing Co-Expression Modules and Machine Learning

Similarity Fusion Via Exploiting High Order Proximity for Cancer Subtyping.

Hierarchical multimodal fusion framework based on noisy label learning and attention mechanism for cancer classification with pathology and genomic features

Subtype Identification from Heterogeneous TCGA Datasets on a Genomic Scale by Multi-View Clustering with Enhanced Consensus.

Integrating Multi-Omic Data with Deep Subspace Fusion Clustering for Cancer Subtype Prediction